The Value Signal — October 02, 2026

734 articles scanned · 15 high-signal

Signal Map

Executive Summary

CMS is hardening mandatory models and pricing levers while Medicare Advantage carriers retreat to margin discipline, so plan generosity is shrinking just as federal accountability expands.

Medicare Advantage is entering 2027 leaner. Wakely notes that CMS has released the 2027 landscape file, and Healthcare Dive finds the national plan count edging down from 5,553 to 5,532, with a Leerink Partners analysis showing the largest carriers cutting dental allowances and premium givebacks despite claims of preserved benefits. Becker's Payer counts 11 payers exiting the program, Advisory Board reports that premiums will dip as insurers leave, and Fierce Healthcare flags a market tilting toward HMOs and C-SNPs. Even so, KFF reports the average beneficiary will still choose among 28 MA-PD plans, with wide variation across states, as UnitedHealth, Aetna and Humana roll out their 2027 offerings, according to Modern Healthcare. On Oversight, HHS OIG finds MA organizations and prescription drug plans paid $72 million over three years for services tied to excluded providers or individuals convicted of certain felonies, sharpening scrutiny of plan integrity controls.

CMMI is pressing ahead with mandatory, episode-based payment. TechTarget reports that the CJR Model's $180 million in savings paves the way for nationwide expansion. Provider resistance is building: according to Becker's ASC, the Texas Medical Association is urging CMS to delay its mandatory specialty model. On Drug Pricing, the American Hospital Association reports that CMS has finalized the GLOBE drug pricing model, adding another federal lever on pharmaceutical spend. In Medicaid, STAT News warns that hundreds of thousands of immigrants with legal status, including refugees and sex-trafficking victims, are at risk of losing coverage starting Oct. 1. That threatens attribution stability and uncompensated-care exposure for safety-net VBC arrangements.